No Fed urgency leaves stocks at risk: JPMorgan
JPMorgan analysts have raised concerns that the current equity market is increasingly a"two-sided debate," with risks stemming from potential growth downturns, uncertain Fed timing, and various geopolitical factors.
The bank explains that in the first half of the year, market attention was largely focused on the trajectory of inflation. However, the second half of the year is shifting attention to growth risks, particularly given the elevated earnings expectations for the latter half of 2024 and for 2025 . The current market pullback is seen as a reaction to fears of weakening growth and a reassessment of recession probabilities.
However, they conclude:"While the recent market flush took out some of the froth, equity positioning and valuation still remain at risk especially if growth continues to decelerate and the Fed does not show urgency."Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Fed's Dudley now calling for Fed rate cut next week amid recession concernsFed's Dudley now calling for Fed rate cut next week amid recession concerns
続きを読む »
Fed's Goolsbee: If economy deteriorates, Fed will fix itIn an interview with CNBC on Monday, Federal Reserve (Fed) Bank of Chicago President Austan Goolsbee noted that there is a lot going on in the world, which makes things more complicated for them, per Reuters.
続きを読む »
Chicago Fed President Goolsbee says if economy deteriorates, Fed will 'fix it'Chicago Federal Reserve President Austan Goolsbee spoke Monday morning on CNBC's 'Squawk Box' program.
続きを読む »
JPMorgan stock price at record high ahead of Q2 earningsJPMorgan earnings kick off earnings season on 12 July, but a slowdown is expected despite the stock’s run to record highs.
続きを読む »
Here are JPMorgan's top stock picks for AugustJPMorgan updated its Analyst Focus List for August, including one addition and two removals from July.
続きを読む »
Here are JPMorgan's top drug stock picks into earningsThese are JPMorgan's top drug picks heading into earnings.
続きを読む »